How to access Xolair from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Emirati patient with moderate-to-severe allergic asthma, chronic spontaneous urticaria (CSU), nasal polyps, or IgE-mediated food allergy may receive a prescription for Xolair (omalizumab) from their treating pulmonologist, allergist, dermatologist, or ENT specialist. Xolair is FDA-approved across all four indications, including the recent approval for reducing allergic reactions to accidental food exposure, and is developed by Genentech and Novartis. It is the longest-established anti-IgE biologic, with more than two decades of post-market safety data. In the UAE, Xolair is registered and available through tertiary hospital pharmacies for asthma and CSU indications; the food allergy indication is newer and availability in the specific dosing and presentation your physician has selected may be inconsistent, which is one driver of the MoHAP named-patient route.
This guide explains the pathway, documentation your physician prepares, indicative timing and how quotes work, and where Reserve Meds fits in.
Ask about Xolair in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Xolair is a humanised IgG1 monoclonal antibody that binds free IgE, preventing IgE from engaging its high-affinity receptor on mast cells and basophils. This reduces the mast-cell / basophil activation that drives allergic asthma, spontaneous urticaria, polyp inflammation, and IgE-mediated food allergy reactions. Dosing is weight- and serum-IgE-banded for allergic asthma and food allergy (75-600 mg every two or four weeks SC), fixed at 300 mg every four weeks for CSU, and either weight-banded or fixed for nasal polyps depending on clinical context. The food allergy indication is distinct, Xolair is approved to reduce the severity of allergic reactions to accidental exposure in IgE-mediated food allergy, not as a cure or as a path away from avoidance. Your physician will confirm indication-specific eligibility and map dosing.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Xolair legally importable into the UAE?
Yes, through the UAE Ministry of Health and Prevention (MoHAP) named-patient / special-access import framework. The pathway permits an Emirati-licensed physician to request import of a medicine when (a) the medicine is approved by a recognised reference authority such as the US FDA or EMA, (b) no clinically equivalent locally available option meets the patient's needs for the specific indication, dose, or presentation, (c) the physician accepts clinical responsibility, and (d) chain of custody is documented. The food allergy indication is particularly common as a named-patient driver given the recency of FDA approval relative to local label updates.
How the pathway works, step by step
- Consultation with your treating specialist. Indication-specific diagnosis and workup, spirometry and allergen panel for asthma, UAS7 scores and autoantibody workup for CSU, nasal polyp scoring for CRSwNP, or specific-IgE and oral food challenge documentation for food allergy.
- Dose calculation. Weight and baseline serum IgE drive the dosing band for allergic asthma and food allergy; fixed dosing applies to CSU.
- MoHAP named-patient application. Your physician or the hospital pharmacy files the application with clinical rationale, indication-specific documentation, and chain-of-custody plan.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure Xolair from authorised distribution under DSCSA.
- Cold-chain shipment. Xolair ships under validated 2-8 °C conditions with temperature logging and chain-of-custody documentation.
- Arrival and administration. First dose administered under clinician observation per labeling (anaphylaxis risk, particularly in food allergy dosing); subsequent doses administered by clinician or, for eligible patients, as prefilled self-injectable presentation.
What documentation your physician needs
- Clinical rationale letter confirming indication, severity, and Xolair as the indicated therapy
- Verification of the UAE medical licence (SCFHS)
- Indication-specific workup (allergen panel, UAS7, polyp score, specific-IgE panel, as applicable)
- Weight and serum total IgE (for weight/IgE-banded indications)
- Planned dosing schedule and follow-up cadence
- Patient identifier (anonymised reference preferred)
Reserve Meds provides a physician documentation kit that bundles the templates MoHAP reviewers expect to see for anti-IgE biologic named-patient imports, including the dosing-band calculator and food-allergy-indication annex.
Typical costs and indicative timing
Medicine price: quote on request. You get a written quote for your case before you commit. International cold-chain logistics, MoHAP documentation handling, and coordination are quoted separately. Reserve Meds issues a full transparent delivered quote at intake so your family sees one landed number.
We give you a written timeline estimate for your case before you commit. Maintenance doses ship on the every-two-week or every-four-week cadence set by your physician.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
Where Reserve Meds fits in
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Xolair specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody from authorised channels.
- Documentation. Regulatory package for your physician and for MoHAP review, including indication-specific templates.
- Logistics. Validated 2-8 °C cold-chain shipment with temperature logging.
- Dedicated case lead. A named point of contact coordinating induction and maintenance refills.
What we do not do: we are not the prescriber, we do not practise medicine, and we are not the dispensing pharmacy. All clinical decisions remain with your treating specialist.
Frequently asked
Is this legal in the UAE? Yes, when executed through the MoHAP named-patient / special-access framework with appropriate documentation. See our trust and compliance page for our methodology.
Is Xolair a cure for food allergy? No. Xolair is approved to reduce the severity of allergic reactions to accidental food exposure in IgE-mediated food allergy. Strict avoidance and emergency-epinephrine carriage remain the standard of care. Your allergist will discuss realistic expectations.
How does Xolair compare with newer severe-asthma biologics? Xolair targets IgE and is the longest-established anti-IgE option; newer biologics target eosinophilic pathways (Fasenra, Nucala), IL-4Rα (Dupixent), or TSLP upstream (Tezspire). Choice depends on phenotype, Xolair remains a leading option for IgE-driven allergic asthma.
What about anaphylaxis risk? Xolair carries a boxed warning for anaphylaxis. First doses are administered under clinical observation per labeling; patients are prescribed emergency epinephrine.
Will private insurance cover this? Cash-pay is the default. Some UAE private insurers reimburse named-patient imports case by case; we supply documentation for your submission but do not process claims directly.
Next step
Examples and timings above are composite illustrations drawn from published sources and typical named-patient patterns. Your individual case is assessed by your physician and our clinical-regulatory team; Reserve Meds does not guarantee outcomes or timelines.
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy, not the prescriber, and not the manufacturer. Cash-pay. Export-only (US → overseas). Composite case examples. Not medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.
Frequently asked questions
How can I get Xolair in the UAE if it is not approved or available there?
Reserve Meds coordinates US-sourced Xolair for patients in the UAE through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for the UAE and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Xolair in the UAE through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Xolair. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in the UAE, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Xolair in the UAE through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Xolair to a patient in the UAE?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Xolair to your treating physician or hospital pharmacy in the UAE, with appropriate handling for the product.
How long does it take, and what does Xolair in the UAE cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Xolair in the UAE?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.